<?xml version="1.0" encoding="UTF-8"?>
<p>Cameroon a sub-Saharan African country situated in Central West Africa, harbours 67% of the Worlds HIV infection [
 <xref rid="pone.0235958.ref015" ref-type="bibr">15</xref>]. Cameroon endorsed the WHO test and treat recommendation in June 2016 [
 <xref rid="pone.0235958.ref016" ref-type="bibr">16</xref>]. Before the endorsement, in 2011 the prevalence of HIV/AIDS epidemic for women was almost twice that of men (5.6% Vs 2.9%) with the greatest epidemiological burden in urban settings [
 <xref rid="pone.0235958.ref017" ref-type="bibr">17</xref>]. Meanwhile ARV drugs through the Ministry of Public Health have been made available free since May 2007 in the National territory of Cameroon for the management of people living with HIV/AIDS (PLHIV) [
 <xref rid="pone.0235958.ref018" ref-type="bibr">18</xref>,
 <xref rid="pone.0235958.ref019" ref-type="bibr">19</xref>], with a total of 151 HIV treatment centers all around the national territory by the end of 2011 [
 <xref rid="pone.0235958.ref019" ref-type="bibr">19</xref>,
 <xref rid="pone.0235958.ref020" ref-type="bibr">20</xref>]. By 2016, there were 205,359 clients receiving HAART [
 <xref rid="pone.0235958.ref016" ref-type="bibr">16</xref>], as compared to 145,038 clients in 2014 [
 <xref rid="pone.0235958.ref021" ref-type="bibr">21</xref>], showing a rapid scale-up of HAART.
</p>
